# Integrated Biopharma Inc > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Integrated Biopharma Inc). ## Overview Integrated BioPharma, Inc. is a Delaware-based nutraceutical company that manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products. Its business is split between contract manufacturing for branded supplement customers and other business lines that include warehousing, fulfillment, and raw-material distribution. ## Products & services • Contract manufacturing of vitamins and nutritional supplements • Nutritional product development and supply for brand owners • Warehousing, fulfillment, and distribution services • Raw-material distribution for nutritional ingredients • Herbal and vitamin product marketing and sales - **Contract Manufacturing** (84%) — Manufactures vitamins and nutritional supplements for third-party brands and distributors. - **Warehousing and Fulfillment** (6%) — Provides storage, order fulfillment, and logistics support through MDC Warehousing and Distribution. - **Raw-Material Distribution** (5%) — Distributes selected raw materials, including nutritional ingredients, through Chem International. - **Other Business Lines** (5%) — Includes inactive subsidiaries and smaller support activities not classified elsewhere. - Contract manufacturing of vitamins and nutritional supplements - Nutritional product development and supply for brand owners - Warehousing, fulfillment, and distribution services - Raw-material distribution for nutritional ingredients - Herbal and vitamin product marketing and sales ## Customers The company sells primarily to branded supplement companies, distributors, multilevel marketers, and specialized health-care providers. Its customer base is highly concentrated, with Life Extension and Herbalife accounting for most consolidated sales in fiscal 2025, while smaller customers use the warehousing and raw-material businesses for logistics and supply support. - **Branded supplement companies** (primary) — Buy contract-manufactured vitamins and supplements for their own distribution channels and brand portfolios. - **Multilevel marketers** (primary) — Source private-label nutraceutical products manufactured to their specifications for direct selling networks. - **Specialized health-care providers** (secondary) — Purchase niche nutritional products and herbal formulations for patient or member use. - **Warehousing and fulfillment clients** (secondary) — Use the company for storage, order processing, and shipping support tied to nutraceutical distribution. - **Raw-material customers** (secondary) — Buy selected nutritional ingredients and related raw materials through the distribution business. - Life Extension and Herbalife are the core contract-manufacturing customers - Distributors buy finished supplements for resale under their own brands - Multilevel marketers source private-label nutraceutical products - Specialized health-care providers buy niche vitamin and supplement products - Warehousing customers use the company for storage and fulfillment services ## Geography The company’s customers are located primarily in the United States and Luxembourg, and its business therefore depends on North American and cross-border nutraceutical demand. Its supply chain also reaches beyond the U.S. for raw materials, capsules, coatings, and packaging, which exposes operations to transportation delays and import-related disruption. - **United States** (80%) — Primary customer and operating market disclosed in MD&A and business description. - **Luxembourg** (20%) — Customer location disclosed in business description; used as a proxy for cross-border demand exposure. - Primary customer demand comes from the United States - Luxembourg is a key customer location through Herbalife-related activity - Raw materials are sourced from the United States and abroad - Transportation delays can affect inbound ingredients and outbound shipments - Geographic concentration increases exposure to U.S. consumer demand ## Strategy Management is focused on retaining its large contract-manufacturing customers while broadening the customer base to reduce concentration risk. It also emphasizes cost control, competitive pricing, and niche international retail products, while investing modestly in machinery and equipment to support operations. - **Reduce customer concentration** (short-term) — Most revenue comes from two customers, so diversification is critical to stabilize sales and cash flow. - **Protect manufacturing competitiveness** (short-term) — Pricing pressure and inflation can compress margins if the company cannot pass through cost increases. - **Selective operational investment** (medium-term) — Machinery, equipment, and fulfillment capacity support service reliability and customer retention. - Retain and deepen relationships with major contract-manufacturing customers - Expand the customer base to reduce revenue concentration - Compete on quality, service, and pricing in a crowded nutraceutical market - Target niche international retail markets for selective growth - Maintain operating discipline and modest capital spending ## Risks The company is highly exposed to customer concentration, with most sales tied to two contract-manufacturing clients. It also faces supply-chain, inflation, regulatory, and cybersecurity risks that are typical for nutraceutical manufacturers but can be amplified by its small scale and reliance on third-party inputs. - **Customer concentration** [critical] — Approximately 84% of consolidated net sales came from two customers in fiscal 2025, so a loss or slowdown would materially hit revenue and margins. - **Supply-chain disruption** [high] — The company depends on timely receipt of raw materials and transportation capacity, which can be disrupted by geopolitical events, shipping delays, or supplier issues. - **Inflation and pricing pressure** [high] — Higher labor, shipping, and supplier costs may not be fully passed through, compressing gross margin. - **Regulatory compliance** [medium] — Nutraceutical products are subject to food, supplement, and manufacturing regulations, and non-compliance could lead to enforcement actions or claims. - **Cybersecurity breach** [medium] — A breach could interrupt systems, expose confidential information, and create remediation and legal costs. - Loss of a major customer could sharply reduce revenue and utilization - Inflation and labor costs may outpace price increases to customers - Raw-material and transportation disruptions can delay production and shipments - Regulatory non-compliance could trigger penalties or product restrictions - Cybersecurity incidents could disrupt operations or expose data ## Accounting Revenue is recognized when title and risk of loss transfer and estimated returns, rebates, charge-backs, and other allowances can be reasonably determined, so sales reserves are important to reported net sales. Investors should also watch inventory valuation, long-lived asset impairment, and deferred tax valuation allowances, because these estimates can move earnings materially for a small manufacturer with concentrated customers and modest asset base. - **Revenue recognition and sales allowances** — Can change reported revenue and gross margin - **Inventory valuation** — Can create write-downs that reduce gross profit - **Long-lived asset impairment** — Can lead to non-cash impairment charges - **Income taxes and valuation allowances** — Can materially affect tax expense and net income - Revenue is reduced by returns, rebates, charge-backs, and other allowances - Credit-loss allowances affect reported net sales and receivables quality - Inventory valuation matters for slow-moving, expired, or obsolete stock - Long-lived asset impairment can affect manufacturing and warehouse assets - Deferred tax valuation allowances reflect use of NOLs and tax assets --- *Last updated: 2026-04-28T20:16:13.954330+00:00*